🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT05767242
Recruiting Observational

Early Neurophysiological Markers of Language Impairments

NCT05767242 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2022-02-21
Last updated
2025-02-05

Condition(s) studied

Development, InfantDevelopment, LanguageDevelopmental Language DisorderLearning Disabilities

Investigational drug(s) / intervention(s)

Electrophysiological recordingBehavioral assessment

Electrophysiological recording: Investigation of early neural markers using electrophysiology at 6-12-24 months

Behavioral assessment: Individual behavioral assessment at later ages (3, 4.5, 6, and 8 years)

Study summary

The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.

Eligibility

Sex
ALL
Min age
6 Months
Max age
8 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy infants aged \<24 months * Infants with and without familial risk for language impairments (infants are assigned to the group with familial risk if at least one first-degree relative had a certified (clinical) diagnosis of language impairment or learning disability * Both parents are native-Italian speakers Exclusion Criteria: * Gestational age \< 37 weeks and/or birth weight \< 2500 grams * APGAR scores at birth at 1' and 5' \< 7 * Bayley Cognitive Score \< 7 * Presence of certified diagnosis of intellectual deficiency, attention-deficit disorder, sensorial and neurological disorders, or autism within first-degree relative

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Associazione La Nostra Famiglia - IRCCS Eugenio Medea Bosisio Parini LC Recruiting

More IRCCS Eugenio Medea trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05767242 on ClinicalTrials.gov ↗ ← All trials in Italy